Astrazeneca Pharmaceuticals Lp Company Profile

Aggregated data from the web about Astrazeneca Pharmaceuticals Lp

Company Name	Astrazeneca Pharmaceuticals Lp
Website	www.astrazeneca.com
Snippet	AstraZeneca plc (/ˌæstrəˈzɛnəkə/) is a British-Swedish multinational pharmaceutical and biotechnology company[2][3][4] with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.[5] It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It has been involved in developing the Oxford-AstraZeneca COVID-19 vaccine.[6]
Type	Public limited company
Founded	1999
Revenue	US$25.890 billion (2020)[1]
Website	www.astrazeneca.com
Industry	PharmaceuticalBiotechnology
Products	Pharmaceutical products
Traded as	LSE: AZNNasdaq Stockholm: AZNNasdaq: AZNFTSE 100 component
Key people	Leif Johansson (Chairman)Pascal Soriot (CEO)
Net income	US$3.144 billion (2020)[1]
Area served	Global
Headquarters	1 Francis Crick Avenue, Cambridge, UK
Predecessors	Astra AB, Zeneca Group plc
Subsidiaries	Alexion PharmaceuticalsMedImmune
Total assets	US$66.729 billion (2020)[1]
Total equity	US$15.638 billion (2020)[1]
Operating income	US$5.162 billion (2020)[1]
Number of employees	76,100 (2020)[1]

Astrazeneca Pharmaceuticals Lp is part of the United Kingdom company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.